Researchers studying yeast cells have identified a metabolic enzyme as a potential therapeutic target for treating Huntington's disease, a fatal inherited neurodegenerative disorder for which there is currently no effective treatment. The group, whose results appear in the May issue of Nature Genetics, includes researchers from the University of Washington School of Medicine in Seattle and the University of Maryland School of Medicine in Baltimore. The paper was published online in advance at the journal's Web site, http://www.nature.com/ng/index.html
The group performed a genetic experiment known as a loss-of-function suppressor screen, which searches for genes that, when switched off, reduce the toxic effects of the mutant protein associated with Huntington's. One of the genes they identified encodes an enzyme, called KMO, that has been previously implicated in the disease. The enzyme functions in a metabolic pathway that is activated at early stages of the disease in people with Huntington's, as well as in animal models of the disease.
"The nice thing about this finding is that there is a chemical compound available that inhibits KMO activity," said Dr. Paul Muchowski, assistant professor of pharmacology at the UW, who led the study. "We're in the midst of testing that compound in a mouse model of Huntington's disease."
Further support for KMO as a therapeutic target for Huntington's disease comes from a recent study led by Dr. Aleksey G. Kazantsev of Harvard Medical School. In this study, researchers used cell-based experiments to screen about 20,000 chemical compounds, and identified one that suppresses neurodegeneration in a fly model of the disease. That compound has a very similar chemical structure as the drug that inhibits the target identified by Muchowski's group. The results appeared in the Jan. 18, 2005, issue of the Proceedings of the National Academy of Sciences.
In adPage: 1 2 Related biology news :1
Contact: Justin Reedy
University of Washington
. Researchers find pathway that controls cell size and division2
. Researchers watch antibiotics, bacteria meet at atomic level3
. Researchers discover gene responsible for Restless Legs Syndrome4
. Researchers witness natural selection at work in dramatic comeback of male butterflies5
. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell6
. Researchers use new approach to predict protein function7
. Researchers probe risks, benefits of folic acid fortification8
. Researchers identify genetic mutation that may alter tumor cell proliferation9
. Researchers discover method for identifying how cancer evades the immune system10
. Researchers use adult stem cells to create soft tissue11
. Researchers find gene that spurs development of the epididymis